Lv2
160 积分 2023-11-09 加入
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
1天前
已完结
Exploring the imaging spectrum of neuroendocrine tumors - an educational exhibit
3个月前
已关闭
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
4个月前
已完结
MRI manifestations of central nervous system leukaemia and cytological analysis of the cerebrospinal fluid
4个月前
已完结
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
8个月前
已完结
Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 study
9个月前
已完结
Efficacy of Novel Agents on Soft-Tissue Plasmacytomas in Patients with Relapsed Multiple Myeloma
11个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
1年前
已完结
中国成人社区获得性肺炎诊断与治疗指南（2016年版）
1年前
已完结
Abstract LB191: The natural compound KH617 targets pediatric and adult high-grade gliomas
1年前
已关闭
皖公网安备34019202002308
